HomeNewsIndiaMondelez India to donate 71 tonnes of biscuits, chocolates in 12 cities

Mondelez India to donate 71 tonnes of biscuits, chocolates in 12 cities

Since food security has become a major concern in the current COVID-19 situation, this association will aid in strengthening various feeding programmes through the company's products which are easy to share and consume.

April 15, 2020 / 15:25 IST
Story continues below Advertisement

Mondelez India Foods Pvt Ltd, manufacturer of Cadbury chocolates, on Wednesday committed to donate 71 tonnes of biscuits and chocolates for distribution in 12 major cities in the country amid the coronavirus pandemic. The company has decided to contribute 360,000 units of biscuits and 23 lakh units of chocolate to India FoodBanking Network, of the Food Security Foundation India, in 12 major cities in the country, it said.

"Mondelez India commits to donate 71 tonnes of biscuits and chocolates as the first step towards extending support to communities during the COVID-19 crisis," the company said in a statement.

Story continues below Advertisement

Follow LIVE updates on the COVID-19 pandemic here

Since food security has become a major concern in the current COVID-19 situation, this association will aid in strengthening various feeding programmes through the company's products which are easy to share and consume.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show